The AGPR Index - novel non-invasive marker in Chronic Hepatitis B Dr.Niharika Harsha B27 July 2022 8:00 PM ISTResearchers from China developed a novel, simple, accurate, and noninvasive marker to predict Liver Fibrosis and Cirrhosis in Chronic Hepatitis B...
Hepatitis-C treatment access in reducing morbidity and mortality among people who inject drugs Isra Zaman12 July 2022 10:00 AM ISTA longitudinal cohort study of persons with a history of injection drug use has found that more people who inject drugs (PWID) are receiving Hepatitis...
Statin use tied to lower risk of acute-on-chronic liver failure in cirrhosis patients: Study Medha Baranwal3 May 2022 11:00 AM ISTUSA: Statin use is significantly associated with reduced development of high-grade acute-on-chronic liver failure (ACLF) in patients with cirrhosis,...
PPIs use improves survival in cirrhosis patients with prior GI bleeding, study shows Medha Baranwal13 April 2022 10:45 PM ISTUSA: A recent study has found that the use of proton pump inhibitors (PPIs) for people with prior gastrointestinal bleeding (GIB) is associated with...
Kisspeptin: A new drug for treatment of NAFLD Dr. Kamal Kant Kohli9 April 2022 10:00 AM ISTGlobally, NAFLD is the most common form of chronic liver disease that affects children and adults and is linked to the rise in obesity and Type 2...
NC-MRI has high sensitivity and an acceptable negative likelihood ratio of HCC detection: Study Dr. Shravani Dali1 March 2022 9:00 AM ISTNon-contrast MRI has moderate negative likelihood ratio with high specificity with acceptable sensitivity for the detection of HCC, even in patients...
IV LOLA combo with lactulose and rifaximin effective in cirrhosis with hepatic encephalopathy: Study Medha Baranwal21 Feb 2022 9:00 AM ISTNew Delhi: A recent study showed a combination of intravenous L-ornithine L-aspartate (LOLA) with lactulose and rifaximin to be better than lactulose...
Management of acute-on-chronic liver failure in cirrhosis and chronic liver disease patients: AJG guideline Medha Baranwal18 Jan 2022 9:00 AM ISTUSA: Acute-on-chronic liver failure (ACLF) is emerging as a major cause of mortality in patients with cirrhosis and chronic liver disease. The recent...
Can exercise protect against fatty liver associated diseases Roshni Dhar11 Jan 2022 4:13 PM IST Worldwide one in four persons is reported to suffer from non-alcoholic liver disease (NAFLD, also called metabolic liver disease MAFLD)....
Metformin independently reduces mortality in patients with cirrhosis and diabetes: Study Dr. Shravani Dali9 Nov 2021 9:00 AM ISTMetformin exposure in patients with cirrhosis and diabetes appears to be safe and is independently associated with reduced overall, but not...
AGA recommends change in testing protocol for cirrhosis patients Hina Zahid6 Nov 2021 9:00 AM ISTBethesda, MD - Patients with cirrhosis, or permanent liver damage, are at higher risk for coagulation disorders, which impact your body's ability to...
DOACs use linked to bleeding in hepatocellular carcinoma: Study Dr. Shravani Dali9 Aug 2021 9:00 PM ISTThe presence of hepatocellular carcinoma is tied with major bleeding, suggests a study published in the Clinical Gastroenterology and Hepatology. ...
